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ABSTRACT
The HIV-1 viral infectivity factor (Vif) allows produc-
tive infection of non-permissive cells (including
most natural HIV-1 targets) by counteracting the
cellular cytosine deaminases APOBEC-3G (hA3G)
and hA3F. The Vif-induced degradation of these
restriction factors by the proteasome has been
extensively studied, but little is known about
the translational repression of hA3G and hA3F by
Vif, which has also been proposed to participate
in Vif function. Here, we studied Vif binding to
hA3G mRNA and its role in translational repression.
Filter binding assays and fluorescence titration
curves revealed that Vif tightly binds to hA3G
mRNA. Vif overall binding affinity was higher for
the 30UTR than for the 50UTR, even though this
region contained at least one high affinity Vif
binding site (apparent Kd=27 6nM). Several Vif
binding sites were identified in 50 and 30UTRs using
RNase footprinting. In vitro translation evidenced
that Vif inhibited hA3G translation by two
mechanisms: a main time-independent process
requiring the 50UTR and an additional time-
dependent, UTR-independent process. Results
using a Vif protein mutated in the multimerization
domain suggested that the molecular mechanism
of translational control is more complicated than a
simple physical blockage of scanning ribosomes.
INTRODUCTION
The human immunodeﬁciency virus-type 1 (HIV-1)
infects primary T-cells, macrophages and monocytes, ulti-
mately leading to the destruction of the immune system,
infection by opportunistic pathogens, and death, if its
replication cannot be inhibited. However, these cell
lineages possess an innate defense system directed
against retroviruses, retrotransposons and retroelements
and HIV-1 had to develop a countermeasure against this
protective system in order to be able to infect them.
Primary T-cells, macrophages and monocytes, as well as
some lymphocyte-derived cell lines, collectively named
non-permissive cells, express two related cytosine
deaminases, APOBEC3G (hA3G) and APOBEC3F
(hA3F) that restrict HIV-1 replication (1,2). However,
these antiviral factors are counteracted by the HIV-1
viral infectivity factor (Vif), a basic 23kDa protein
required for HIV-1 propagation in vivo and path-
ogenesis (1–5).
The N- and C-terminal domains of hA3G and hA3F
possess signiﬁcant similarity to APOBEC1, the catalytic
subunit of the mammalian apolipoprotein B mRNA
editing enzyme. The APOBEC family includes the
cellular cytidine deaminases APOBEC1, APOBEC2,
APOBEC3, APOBEC4 and the activation-induced
deaminase (AID). In humans, there are seven apobec3
genes coding for hA3A, hA3B, hA3C, hA3DE, hA3F,
hA3G and hA3H (3–6). Among these proteins, hA3G
has the most potent anti-HIV-1 activity, while the
activity of hA3F is weaker but signiﬁcant, and the anti-
HIV-1 activity of hA3DE is very weak (3,4). Other
APOBEC3 members display potent activities against
various viruses and retroelements (3). In the absence of
Vif (i.e. in HIV-1 vif), hA3G and hA3F are incorporated
into HIV-1 and they catalyze cytosine deamination during
( ) strand DNA synthesis, ultimately resulting in
(i) degradation of the viral DNA and/or (ii) lethal hyper-
mutagenesis (1,2,7–12). Notably, accumulating evidence
shows that catalytically inactive hA3G and hA3F
mutants also signiﬁcantly inhibit HIV-1 DNA synthesis
and replication (3–5), and some of the antiviral eﬀects of
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particles.
HIV-1 Vif decreases the intracellular concentration of
hA3G and hA3F and prevents their incorporation into
HIV-1 particles (7–9,13–16). HIV-1 Vif suppresses hA3G
and hA3F antiviral functions by hijacking a cellular E3
ubiquitin ligase and inducing their degradation by the 26S
proteasome (8,10–12,16–18). Even though the Vif
induced-degradation of hA3G by the 26S proteasome
has been extensively studied, it is not the only mechanism,
and possibly not the main mechanism, by which Vif
counteracts hA3G and hA3F. Indeed, Vif has been
shown to be able to inhibit packaging and antiviral
activity of a degradation resistant hA3G variant (19). In
one of the ﬁrst publications in the ﬁeld, Landau and
coworkers reported a 4.6-fold reduction of hAG3 synthe-
sis in the presence of Vif and concluded that Vif-induced
degradation of hA3G does not appear to be the primary
mechanism by which it blocked hA3G encapsidation (7).
It is possible that the Vif-induced, proteasome-dependent,
degradation of Vif was underestimated in this study (8,10),
but the eﬀect of Vif on hA3G synthesis was conﬁrmed by
several independent groups (10,13). The mechanism by
which Vif downregulates hA3G translation has never
been studied.
Recently, we showed that Vif binds the 50-region of the
HIV-1 genomic RNA with high aﬃnity and moderate
cooperativity (20,21), and that Vif has an RNA chaperone
activity (22). In addition, mutations reducing the aﬃnity
of Vif for RNA have been shown to diminish viral repli-
cation in non-permissive cells (23), suggesting that RNA
binding plays a central role in Vif function. We therefore
studied binding of HIV-1 Vif to hA3G mRNA by bio-
chemical and biophysical methods. As the 50 and
30UTRs of mRNAs are often involved in negative
translational control by proteins (24,25), we compared
Vif binding to the full-length mRNA and RNA fragments
corresponding to the 50 and 30UTRs and to the hA3G
coding region. Our results showed that wild-type Vif has
a high aﬃnity for the hA3G mRNA, and especially for its
30 UTR. Using chemical and enzymatic footprinting, we
identiﬁed several Vif binding sites not only in the 30UTR,
but also in the 50UTR of hA3G mRNA. Finally, we
compared the eﬀect of Vif on the in vitro translation of
full-length hA3G mRNA and mRNAs lacking the 50
or/and 30UTR(s) regions. Vif had two negative eﬀects on
hA3G translation: a time-dependent, UTR-independent
eﬀect and a more important time-independent eﬀect that
required the 50UTR. Our results suggest that Vif binding
to hA3G mRNA, and particularly to its 50UTR might be
crucial for Vif function, by downregulating hA3G
translation.
MATERIALS AND METHODS
Plasmid construction
The DNA sequence corresponding to hA3G was obtained
after polyA
+ mRNA isolation from H9 cells (PolyATt
ract mRNA Isolation Systems—Promega) and RT–
PCR analysis (Superscript—Invitrogen) using a sense
primer corresponding to the major transcription site
deﬁned by Muckenfuss et al. (26) and an antisense
primer corresponding to the 30-end of the 30UTR
(Table 1). Ampliﬁed PCR products containing the entire
human hA3G mRNA sequence were digested by EcoRI
and XbaI and ligated into pCMV6-XL5 previously
digested with the same restriction enzymes. Fragments
corresponding to the 50UTR, the 30UTR or the coding
region   the 50 and/or the 30UTR of hA3G mRNA were
PCR ampliﬁed using primers listed in Table 1 and cloned
into pCR TOPO 2.1 (Invitrogen), for in vitro run oﬀ tran-
scription, and pCMV6-XL5, for in vitro translation
assays. The resulting plasmids pCMV-hA3G, pCMV-
hA3GUTR, pCMV-hA3G50UTR and pCMV-
hA3G30UTR contain nucleotides 1–1771, 298–1452,
298–1771 and 1–1432 of hA3G, respectively and
pTOPO-hA3G-50UTR and pTOPO-hA3G-30UTR
contain nucleotides 1–297 and 1454–1771, respectively.
The inserts of all plasmids were checked by sequence
analysis. All nucleotide positions refer to the transcription
start site of the major isoform corresponding to hA3G
mRNA in human T-cell lines A3.01 (26).
Plasmid pD10 WT-Vif containing a 6His-tag fused
at the N-terminal domain of Vif lacking the methionine
initiation codon was used to perform site-directed
mutagenesis (QuickChange mutagenesis—Stratagene) to
obtain a Vif protein mutated in the multimerization
domain 161PPLP164. The proline residues were replaced
by alanines using oligonucleotides vif-M1 et vif-M2 as
indicated in Table 1. The presence of the mutation was
checked in the resulting plasmid, pD10 AALA-Vif, by
DNA sequencing.
RNA synthesis and labeling
After linearization of plasmids pCMV-hA3G, pCMV-
hA3GUTR, pCMV-hA3G50UTR, pCMV-hA3G
30UTR, pCRTOPO-hA3G50UTR or pCRTOPO-
hA3G30UTR by StuI or XbaI, in vitro transcription was
performed with bacteriophage T7 RNA polymerase in
presence of  -
32P ATP (Amersham) as described earlier
(27). Internally labeled RNA was puriﬁed on denaturing
polyacrylamide gels or on agarose gels.
Recombinant Vif proteins
Expression plasmids pD10WTVif or pD10AALAVif were
used to transform Escherichia coli BL21 cells as described
(28). Detailed protocols of Vif expression and puriﬁcation,
as well as a biophysical characterization of the wild-type
and mutant Vif proteins will be published elsewhere
(S. Bernacchi, et al., manuscript in preparation). Brieﬂy,
Vif proteins were puriﬁed under denaturing conditions
using a Ni-NTA column. After elution, proteins were
renaturated by slow dialysis against buﬀers with
decreasing guadinium chloride concentration, and ﬁnally
against a buﬀer containing 50mM MOPS pH 6.5, 150mM
NaCl, 10% glycerol. Vif proteins were stored in small
aliquots at  80 C and kept at 4 C after thawing. As
both wild-type and AALA Vif tend to aggregate, the
protein stock solutions were centrifuged at 100000g for
30min at 4 C immediately prior use. The protein
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spectrophotometrically using an extinction coeﬃcient of
43040cm
 1M
 1 at 280nm. UV spectroscopy revealed
that puriﬁed Vif proteins were not contaminated by
nucleic acids.
Filter binding assays
Internally
32P-labeled full-length or truncated hA3G
mRNA (20000c.p.m., ﬁnal concentration <2nM) and
1.5mg of unlabeled E. coli total tRNA in 5ml of Milli-Q
(Millipore) water were heated for 2min at 90 C and
chilled on ice for 2min. After addition of 10-fold
concentrated binding buﬀer [ﬁnal concentrations: 30mM
Tris–HCl (pH 7.5), 300mM NaCl, 2.5mM MgCl2],
1.4mM b-mercaptoethanol and 5 Us of RNasin
(Promega), RNA was renatured for 15min at 37 C. In
parallel, Vif proteins were renatured for 15min at 37 C
in binding buﬀer supplemented with 0.02% (w/v) bovine
serum albumin, and added to RNA in a ﬁnal volume of
60 ml. After incubation for 30min at 37 C and for 30min
at 4 C in the presence of 0.01% Triton X-100, RNA–
protein complexes were loaded onto 0.45mm pore size cel-
lulose ﬁlters (MultiscreenTM 96-well plate, Millipore),
presoaked with 100ml of binding buﬀer. After three
washes with 100ml of ice-cold binding buﬀer, the ﬁlters
were air-dried and the radioactivity remaining on the
ﬁlters was determined by liquid scintillation counting.
Quantitative analysis of ﬁlter-binding assays
The hypothesis underlying ﬁlter binding assays is that all
RNA–protein complexes are retained on the ﬁlter. As we
previously showed that Vif binds RNA cooperatively
(20,21), ﬁlter binding data can be analyzed using the Hill
equation for cooperative binding (21). Curve ﬁtting of the
experimental data was performed with Origin7 or Prism5
softwares using equation:
f ¼
L ½ 
 H
Kd ðÞ
 Hþ L ½ 
 H 1
where f corresponds to the RNA fraction retained on the
ﬁlter, [L] is the protein concentration,  H is the Hill
constant and is an index to the cooperativity and Kd is
the ligand concentration at which 50% of the RNA is
retained on the ﬁlter.
Steady-state ﬂuorescence measurements
Fluorescence experiments were recorded in quartz cells at
20 0.5 C on a Fluoromax-4 ﬂuorometer (HORIBA
Jobin–Yvon). The excitation wavelength was 295nm, the
emission wavelength was scanned from 310 to 450nm, the
integration time was 0.1s, and the excitation and emission
bandwidths were 5nm. Fluorescence titrations were
performed by adding increasing amounts of nucleic acid
to 100nM or 50nM Vif in 30mM Tris–HCl (pH 7.5),
200mM NaCl and 10mM MgCl2.
Determination of Vif/RNA binding parameters
To determine the binding parameters of Vif to the hA3G
mRNA fragments, we measured the decrease of the ﬂuo-
rescence intensity, I, at a ﬁxed concentration of protein in
presence of increasing RNA concentrations. The ﬂuores-
cence intensity was then converted into the intrinsic ﬂuo-
rescence quenching Qobs in Equation 2:
Qobs ¼
I0   I
I0
2
with I0 corresponding to the protein ﬂuorescence intensity
in absence of nucleic acid. The number of consecutive
nucleotides occluded upon binding of one ligand, n, the
observed aﬃnity, Kobs and the cooperativity parameter, !,
were recovered using the model of McGhee and von
Hippel for cooperative binding (29), in Equation 3:
 
Lf
¼ Kobs  ð 1   n Þ 
ð2!   1Þð1   n Þþ    R ½  n 1
2ð!   1Þð1   n Þ ½  n 1
 
1  ð n þ 1Þ  þ R ½  2
2ð1   n Þ ½  2
3
with R={[1 (n+1)v]
2+4v(1 nv)}
1/2.
Table 1. Oligonucleotides used in this study
RNA Primers
hA3G pS 1–21 EcoRI-TCTTTCCCTTTGCAATTGCC
pAS 1750–1771 XbaI-AAGATTTAGTATTTCATTT
hA3G-UTR pS 298–321 EcoRI-GGATGAAGCCTCACTTCAGAAACAC
pAS 1432–1452 XbaI-TCAGTTTTCCTGATTCTGGAG
hA3G-50UTR pS 298–321 EcoRI-GGATGAAGCCTCACTTCAGAAACAC
pAS 1750–1771 XbaI-AAGATTTAGTATTTCATTT
hA3G-30UTR pS 1–21 EcoRI EcoRI-TCTTTCCCTTTGCAATTGCC
pAS 1432–1452 XbaI-TCAGTTTTCCTGATTCTGGAG
hA3G-50UTR pST7 1–21 EcoRI-T7-TCTTTCCCTTTGCAATTGCC
pAS 277–297 StuI-TGGCCGGCTAGTCCCGAC
hA3G-30UTR pST7 1454–1478 EcoRI-T7-GGATGGGCCTCAGTCTCTAAGGAAG
pAS 1750–1771 XbaI-AAGATTTAGTATTTCATTT
Vif AALA pSAALA hVif CCAAAACAGATAAAGGCAGCATTGGCAAGTGTTAGGAAACTG
pASAALA hVif CAGTTTCCTAACACTTGCCAATGCTGCCTTTATCTGTTTTGG
Nucleic AcidsResearch, 2010, Vol.38,No. 2 635Because the McGhee and von Hippel (30) model was
derived with the simplifying assumption of an inﬁnite
lattice of binding sites, we introduced a correction factor
taking into account the ﬁnite lattice size, N. The correction
merely amounts to multiplying Equation 3 by the factor
(N n+1)/(N)
For !=1, Equation 3 simpliﬁes to Equation 4, which
corresponds to the Scatchard formulation for non-
interacting ligands:
 
Lf
¼ Kobs  ð 1   n Þ 
1   n 
1  ð n   1Þ  
 n 1
4
where   corresponds to the binding density (mol of bound
protein/mol of nucleotide), and Lf to the concentration of
free protein. These quantities are linked by Equations 5–7
as described in (31):
  ¼ Lb=Dt 5
Lf ¼ Lt   Lb 6
Lb ¼ Lt Qobs=Qmax ðÞ 7
where Dt is the total nucleotide concentration, Lt and
Lb are the total and the bound protein concentrations,
respectively, and Qmax corresponds to the maximal ﬂuo-
rescence quenching when all protein molecules are bound
to nucleic acids. Fitting of experimental data with those
equations was performed with an algorithm written with
Mathematica (Wolfram Research) (20).
Chemical modiﬁcations of RNA and enzymatic footprinting
Chemical modiﬁcation experiments were performed on the
full-length hA3G mRNA and on the hA3G-50UTR and
hA3G-30UTR RNAs. RNAs were modiﬁed with DMS
(Fluka) or CMCT (Merck) after a renaturation procedure
in a high ionic strength buﬀer in the presence of 2mgo f
E. coli total tRNA. For DMS modiﬁcation, the reaction
was carried out in buﬀer D1 (50mM sodium cacodylate,
pH 7.5, 300mM KCl, 5mM MgCl2) for 4 and 8min at
37 C with DMS freshly diluted 1/20 (v/v) in ethanol. For
CMCT, modiﬁcations were performed at 25 C in buﬀer
D2 (100mM sodium borate pH 8.0, 300mM KCl and
5mM MgCl2) with 5ml of freshly dissolved CMCT
(42mg/mlin water) for 15, 30 and 45min. Reactions
were stopped by precipitation in ethanol. Modiﬁed/pro-
tected bases were detected by extension of a 50
32P-labeled primer with avian myeloblastosis virus
reverse transcriptase (MP Bio-medicals) as described
earlier (21) and analyzed on denaturing 8%
polyacrylamide gels.
Enzymatic footprinting experiments were performed on
hA3G-50UTR and hA3G-30UTR RNAs in the presence
of increasing concentrations of Vif using ribonuclease
(RNase) V1, T1 and A (Ambion). Brieﬂy, RNA (1mM)
was renatured for 15minin the presence of 2mgo fE. coli
total tRNA in the buﬀer provided by the manufacturer.
After addition of Vif protein (0, 0.5, 1.0, 2.0 and 3.0mM),
Vif–RNA complexes were allowed to form for 30min at
37 C and 30min at 4 C. RNases V1, T1 or A were then
added and incubation was continued for 15min at room
temperature. Reactions were stopped by phenol/chloro-
form extraction and ethanol precipitation. Footprints
were detected by primer extension as described earlier (21).
In vitro translation assays
The wild-type and mutant Vif proteins, and control
AspRS were transcribed and translated for 90min at
30 C using the Promega TNT T7-coupled reticulocyte
lysate system according to the manufacturer’s
instructions. The synthesized Vif, Vif AALA or AspRS
were added on ice to a new transcription/translation
mix containing either pCMV-hA3G, hA3GUTR,
hA3G50UTR or hA3G30UTR. The reaction media
were then incubated for 15, 30, 45 or 60min at 30 C
and stopped on ice by the addition of SDS–PAGE
loading buﬀer. Proteins were then separated on 12.5%
SDS–PAGE and analyzed by autoradiography.
RESULTS
Characterization of wild-type and AALA Vif proteins
Due to the tendency of wild-type and AALA Vif proteins
to aggregate, they were centrifuged at 100000g prior each
experiments and only the soluble fraction of the proteins
was used. The soluble proteins were further characterized
by size-exclusion chromatography and dynamic light scat-
tering. Both techniques indicated that wild-type Vif self-
associates into homogenous oligomers containing 6–10
proteins, while Vif AALA formed dimers or/and trimers
(S. Bernacchi et al., manuscript in preparation). Thus,
even though the PPLP motif is important for Vif multi-
merization, its mutation does not completely abolish Vif
self-association.
Filter binding assays
In order to detect and analyze binding of wild type (WT)
HIV-1 Vif to hA3G mRNA, we ﬁrst performed ﬁlter
binding assays using either full-length hA3G mRNA,
mRNAs deleted of the 50 or the 30UTR or RNA fragments
corresponding to the 50UTR, the hA3G coding region or
the 30UTR, respectively (Figure 1A). All binding curves
displayed a sigmoid shape suggesting that binding of Vif
to the hA3G mRNA and the fragments thereof is cooper-
ative (Figure 2A). The experimental data were adequately
ﬁtted with the Hill equation (Figure 2A), and the apparent
dissociation constants (Kd) and the Hill constant ( H),
which reﬂect cooperativity, extracted from this analysis
are summarized in Table 2. No cooperativity corresponds
to  H=1, while  H>1 indicates positive cooperativity.
In addition,  H gives a lower limit of the number of Vif
binding sites on RNA. For this analysis and all other
quantitative analyses in the next sections, the Vif
concentrations were expressed as concentrations of Vif
monomers, even though characterization of wild-type
and AALA Vif proteins indicated that they are oligomeric
(see above). Indeed, as we do not know how many RNA
binding sites are present per Vif oligomer, it would be very
speculative to use more complex models. All dissociation
constants must therefore be considered as apparent
636 Nucleic Acids Research, 2010,Vol. 38,No. 2dissociation constants, which are nevertheless very useful
to compare Vif binding to diﬀerent RNA species.
Comparison of hA3G-UTR, hA3G-50UTR, and
hA3G-30UTR RNAs showed that WT Vif bound to
these three regions with signiﬁcant aﬃnity, especially as
the binding buﬀer contained high salt concentration in
order to reduced unspeciﬁc electrostatic interactions.
However, Vif displayed a higher aﬃnity for the 30UTR
of hA3G mRNA, while binding to the coding region
was slightly weaker than to the 50UTR (Figure 2A and
Table 2). These experiments suggested that the 30UTR of
hA3G mRNA contains at least one high aﬃnity Vif
binding site. In keeping with this interpretation, WT Vif
binds tighter to hA3G and hA3G-50UTR RNAs, which
contain the 30UTR, than to hA3G-30UTR (Table 2). WT
Vif appeared to bind all RNA fragments with moderate
cooperativity.
Unexpectedly, Vif bound hA3G and hA3G-50UTR
RNAs weaker than hA3G-30UTR RNA, even though
these three RNAs contain the same high aﬃnity Vif
binding site(s). This result revealed that the assumption
that all RNA–protein complexes are retained with the
same eﬃciency on the cellulose membrane was not ful-
ﬁlled. Instead, retention of the RNA–Vif complexes on
the ﬁlter probably increased as an increasing number of
proteins bound to the same RNA molecule. Even though a
theoretical framework has been developed to determine
the retention eﬃciency of RNA–protein complexes in
ﬁlter binding experiments (32), it could not be applied to
our experiments, which involved an unkown number of
RNA–protein complexes with diﬀerent retention
eﬃciencies. Thus, the Kd values in Table 2 do not
correspond to the binding dissociation constant of Vif
from the highest aﬃnity binding site present in each
RNA fragment, but correspond to a weighted average of
the binding dissociation constants of all binding sites
present on each RNA.
As Vif multimerization is required to counteract the
antiviral activity of hA3G (4,33–35), and as it would
also help to explain the cooperative binding of this
protein to hA3G mRNA, we mutated the Vif
multimerization domain, which has been mapped to the
161PPLP164 motif (Figure 1) (36). Detailed characteriza-
tion of the WT and mutant Vif proteins will be described
elsewhere (S. Bernacchi et al., manuscript in preparation).
Interestingly, we observed that mutation of the PPLP
motif did decrease the oligomerization of Vif but did not
totally prevent it, as Vif AALA behaved as dimers or/and
trimers (see above and S. Bernacchi et al., manuscript in
preparation). As compared to WT Vif, the mutant Vif
AALA protein displayed very little preference for any of
the RNA fragments we tested (Figure 2 and Table 2).
While the mutant Vif had a slightly stronger aﬃnity for
the isolated 30UTR than for the 50UTR, it also displayed a
slightly better aﬃnity for the hA3G-30UTR RNA than
for the hA3G-50UTR. Thus, it seems that the mutant Vif
did not display any global preference for one of the UTR
or for the coding region of the hA3G mRNA. However
the PPLP motif was not required for cooperative binding,
since  H values were consistently higher for Vif AALA
than for WT Vif (Table 2).
Fluorescence spectroscopy
In order to reinforce the conclusions drawn from the ﬁlter
binding experiments, we studied Vif binding to the hA3G
mRNA by ﬂuorescence spectroscopy. HIV-1 Vif protein
contains eight Trp residues, including seven that are
located in the N-terminal region of Vif, which corresponds
to the RNA binding domain (4,36). Thus, Vif displays a
high intrinsic ﬂuorescence that is quenched upon binding
to nucleic acids (20). While increasing amounts of protein
were used to titrate a negligible amount of RNA in the
ﬁlter binding assays, a constant and non negligible
amount (50 or 100nM) of protein was titrated with
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Figure 1. Schematic representation of the RNA and Vif proteins used in this study. (A) Representation of the full-length hA3G mRNA and the
truncated RNAs. The coding region is indicated by a black box. (B) Scheme of the Vif protein. The name of the viral and cellular partners that
interact with diﬀerent regions of Vif are indicated. CUL5: Cullin 5; ELOC: Elongin C; GAG: HIV-1 Pr55
Gag precursor. The sequence of the
multimerization domain of the WT protein and of the Vif AALA mutant are indicated.
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experiments. Thus, the same formalism could not be
used to analyze the two kinds of binding curves, and we
analyzed the ﬂuorescence binding curves using the
McGhee and von Hippel model for cooperative binding
(see ‘Materials and Methods’ section).
Compared to the ﬁlter binding assays, ﬂuorescence
titrations consistently yielded lower Kobs (Table 3), as
expected if several Vif proteins have to bind to a same
RNA molecule to obtain complete retention of the
complexes on the ﬁlters. Alternatively, this diﬀerence
might also indicate that some Vif–RNA complexes disso-
ciate during washing of the ﬁlters. However, both
techniques indicated that WT Vif bound all RNA
fragments with moderate cooperativity. Fluorescence
titration curves revealed that WT Vif had a high aﬃnity
for hA3G-30UTR RNA, in agreement with ﬁlter binding
assays, but also for hA3G-UTR RNA, a feature not
observed in the previous experiments (Table 3). As a
result, Vif also demonstrated a high aﬃnity for all
RNA fragments containing either the 30UTR or the
coding region of hA3G mRNA. Note that as binding
cooperativity is not extremely high, the Kobs values
derived from the ﬂuorescence titrations are mean values
of all binding events quenching the Vif ﬂuorescence,
whereas, as previously pointed out, the Kd values derived
from the ﬁlter binding assay are aﬀected by the diﬀerential
retention of the Vif–RNA complexes on the ﬁlters. Thus,
diﬀerences in the Kd and Kobs values obtained by these two
techniques are not completely unexpected.
The ﬂuorescence binding curves also allowed determi-
nation of the binding stoichiometry of Vif to the various
RNA fragments from the intersection of the initial slope
with the ﬂuorescence plateau (Table 3 and data not
shown) (20). Indeed, only a limited number of Vif
monomers bound to the full-length hA3G mRNA, with
as few as 2–4 Vif molecules binding to the coding region,
and the 30 and 50UTRs (Table 3). Indeed, this low
stoichiometry indicates that there are several RNA
binding sites per wild-type Vif oligomer (corresponding
to  9 Vif monomers). In addition, the Vif binding
density is signiﬁcantly higher ( 1 protein/100 nucleotides)
in the UTRs than in the hA3G coding region ( 1/400
nucleotides) (Table 3).
In an attempt to get a better estimation of the binding
aﬃnity of Vif for the highest aﬃnity binding site present in
each of the hA3G-50UTR, hA3G-UTR and hA3G-
30UTR RNAs, we analyzed the ﬂuorescence binding
data using the Scatchard equation (see ‘Materials and
Methods’ section). This analysis is justiﬁed because these
RNAs bound only a few Vif molecules (Table 3). When
plotting the fraction of the bound to unbound protein as a
function of the fraction of bound protein, the ﬂuorescence
binding data was linear over a wide range of RNA con-
centration (Figure 3A), indicating that these data can
indeed be used to determine the Kd of Vif for the highest
aﬃnity binding site present in each RNA (KSca). Fitting
the data from several experiments with Equation 4
yielded KSca values of 27 6, 24 5 and 37 4nM for
hA3G-50UTR, hA3G-30UTR and hA3G-UTR RNAs,
respectively (Table 4). Expectedly, these values are lower
than the ‘mean values’ obtained from the same data with
the McGhee and von Hippel equation (Table 3). They
reveal that the highest aﬃnity binding sites present in
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Figure 2. Titration curves of full-length and truncated hA3G mRNA
by Vif determined by ﬁlter binding. Radiolabeled full-length hA3G
mRNA or hA3G mRNA fragments were incubated with increasing
concentration of WT Vif (A) or Vif AALA (B), and ﬁltered through
a cellulose membrane. The fraction of bound radioactivity is plotted
versus the concentration of Vif. Curves correspond to the best ﬁt of
equation (1) to the experimental data. The data points represent the
mean SD of >10 experiments after exclusion of outliers falling
outside of the 95% conﬁdence interval.
Table 2. Binding parameters derived from the ﬁlter binding assays
WT Vif Vif AALA
RNA Ka
d(nM)  H Kd (nM)  H
hA3G 120 10
b 2.0 0.3 276 23 2.4 0.2
hA3G-50UTR 112 5 1.9 0.1 231 14 3.0 0.3
hA3G-30UTR 148 11 1.9 0.2 202 7 3.4 0.3
hA3G-UTR 145 8 2.3 0.3 261 11 2.7 0.2
hA3G-50UTR 115 4 2.6 0.2 292 18 3.0 0.3
hA3G-30UTR 57 3 2.3 0.2 204 8 3.3 0.3
aKd and  H were obtained by ﬁtting the experimental data to the Hill
equation (see ‘Materials and Methods’ section).
bMean SD.
638 Nucleic Acids Research, 2010,Vol. 38,No. 2the 50 and 30UTRs of hA3G mRNA bind Vif equally well,
whereas binding to the highest aﬃnity binding site located
in the coding region is signiﬁcantly weaker.
Filter binding experiments indicated that the mutant Vif
AALA has a signiﬁcantly reduced aﬃnity for A3G mRNA
(Figure 2B and Table 2). Fluorescence titration and
Scatchard analysis using this protein (Figure 3B and
Table 4) yielded unexpected results. Indeed, the aﬃnity
of Vif AALA for the highest aﬃnity binding sites
present in hA3G-50UTR, hA3G-30UTR and hA3G-
UTR RNAs was not decreased. On the contrary, the
KSca values determined for the mutant protein were
reproducibly 2- to 3-fold lower than for the wild-type
protein (Table 4). This diﬀerence in the KSca values may
not reﬂect a higher aﬃnity of the mutant protein for these
sites, but may be the consequence of the lower
oligomerization state of the mutant Vif protein. Indeed,
the KSca values likely reﬂect binding of the ﬁrst Vif
oligomer to a single RNA binding site, and thus it
would be appropriate to express the Vif concentrations
as concentration of Vif oligomers for this analysis. We
choose not to do so for a matter of consistency throughout
the present study. Nevertheless, the important point is that
although mutation of the PPLP motif decreases the overall
aﬃnity of Vif for hA3G mRNA and fragments thereof, it
does not reduce the aﬃnity for the highest aﬃnity binding
sites present in hA3G-50UTR, hA3G-30UTR and hA3G-
UTR RNAs.
RNA probing and footprinting of Vif
To further investigate Vif binding to hA3G mRNA and its
possible role in regulating hA3G translation, we next used
chemical and enzymatic probing to determine the second-
ary structure of this mRNA and enzymatic footprinting to
identify Vif binding sites. As the 50 and 30UTRs play an
important role in the translational regulation of many
mRNAs (24,25), we focused our structural analysis on
these regions.
To test whether the 50 and 30UTRs fold independently
or whether they interact with each other or with the hA3G
coding region, we ﬁrst incubated hA3G-50UTR RNA with
hA3G-50UTR RNA and hA3G-30UTR RNA with
hA3G-30UTR in a high salt and Mg
2+ buﬀer. Agarose
gel electrophoresis performed at 4 C revealed no complex,
strongly suggesting that no long range interaction takes
place between the 50UTR, the coding region, and the
30UTR of the hA3G mRNA (data not shown) (37).
Accordingly, no signiﬁcant diﬀerence was found when
chemical probing was performed on full-length hA3G
mRNA or on hA3G-50UTR and hA3G-30UTR RNAs
(Figures 4 and 5, and data not shown).
Table 3. Binding parameters derived from analysis of the ﬂuorescence
titration curves using the model of McGhee and von Hippel
RNA Kobs (nM)
a !
a Stoichiometry
c RNA length (nt)
hA3G 36 6
b 108  6–7 vif/RNA 1773
hA3G-50UTR 42 57 8  2–4 vif/RNA 1476
hA3G-30UTR 40 2 109  2–3 vif/RNA 1452
hA3G-UTR 46 77 6  2–3 vif/RNA 1155
hA3G-50UTR 120 16 254  3–4 vif/RNA 297
hA3G-30UTR 49 11 125  3–4 vif/RNA 321
aKobs and ! values were obtained by ﬁtting the experimental data to
equation 3 (see ‘Materials and Methods’ section).
bMean SD of at least three experiments.
cThe binding stoichiometry was determined graphically from the ﬂuo-
rescence binding curves (see text).
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Figure 3. Scatchard representation of the ﬂuorescence binding data of
wild-type Vif (A) and Vif AALA (B) to hA3G-50UTR, hA3G-30UTR,
and hA3G-UTR RNAs. The ratio of bound to unbound Vif is
plotted as a function of the fraction of bound protein.
Table 4. Determination of the apparent dissociation constant (KSca)o f
the highest aﬃnity Vif binding site using the Scatchard equation
RNA KSca (nM)
a
WT Vif Vif AALA
hA3G-50UTR 27 6
b 9 2
hA3G-30UTR 24 51 1  1
hA3G-UTR 37 42 0  6
aKSca values were obtained by ﬁtting the experimental data to
Equation 4 (see ‘Materials and Methods’ section).
bMean SD of at least three experiments.
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Nucleic AcidsResearch, 2010, Vol.38,No. 2 641The 50UTR of hA3G mRNA. As indicated by probing with
DMS, CMCT, RNAse A and RNase T1, two chemicals
and two RNases that speciﬁcally modify or cleave
unpaired nucleotides, and RNase V1, which cuts paired
and stacked residues, the 50UTR of hA3G mRNA folds
into three structured domains separated by single-
stranded junctions (Figure 4). Most nucleotides in the
50-J12 and 50-J23 junctions were slightly to highly
reactive towards chemical and 50-J23 was also cleaved by
RNase A (Figure 4A and D). The structure of the
structured domains (50-D1 to 50-D3) was also
unambiguous. Most nucleotides in the stems were not
reactive, except some moderate reactivity close to some
helix ends. In addition, the existence of several stems
in 50-D1 and 50-D3 was conﬁrmed by RNase V1 cuts
(Figure 4B–D). On the other hand, as expected, most
nucleotides that are single-stranded in our model were
strongly modiﬁed by chemicals or/and cut by RNases A
and T1 (Figure 4A and D). The only ambiguous region in
the 50-UTR of hA3G mRNA is the 50-strand of the upper
internal loop of 50-D1 (52–55nt). This loop was
simultaneously cleaved by RNases A and V1, while
theses nucleotides were reactive to CMCT and DMS, sug-
gesting that these nucleotides are unpaired but stacked.
The RNAse V1 cleavages in this region increased upon
addition of increasing Vif concentration, except at the
highest Vif concentration (3mM) at which they almost
completely disappear. It is plausible that Vif binds ﬁrst
to the adjacent unstable stem (46–50nt), increasing
stacking of the internal loop, then binds to the loop
itself at 3mM Vif. However, this internal loop must be
regarded as a weak Vif binding site, considering the Vif
concentration at which protection was observed. No Vif
footprint was detected in 50-D2, while several were
detected in 50-D3 (Figure 4C and D). RNase V1 cleavages
at nt 212–218 were strongly inhibited at  1mM Vif,
reﬂecting Vif binding to the lower helix of 50-D3.
Similarly, RNAse V1 cleavages at 257–262nt and
RNAse V1 and RNase A cleavages at 265–267nt were
strongly protected at 2mM Vif (Figure 4C and D). These
two regions may either represent a unique Vif binding site
or two contiguous binding sites.
The 30UTR of hA3G mRNA. Chemical and enzymatic
probing of the 30-UTR of hA3G mRNA revealed that it
also consists in three independent structural domains
separated by two single stranded junctions (Figure 5).
Junction 30-J23 was highly reactive towards chemical
probes, while most nucleotides in 30-J12 were only
slightly reactive (Figure 5A and D). Indeed, the 30-J12
30 half may form an unstable helix with the very 30-end
of the 30UTR (Figure 5D). The model structure of 30-D1 is
well supported by experimental data: nucleotides involved
in helices were not reactive towards chemicals, except at
the end of some helices, and the existence of most helices
was supported by RNase V1 cleavages (Figure 5C and D).
The proposed structure of domain 30-D2 is in good agree-
ment with experimental data, except for a weak RNase A
cut after nt U1621, which is located in the middle of a
helix, as supported by the lack of reactivity of the neigh-
boring nucleotides (Figure 5A, B and D). The short apical
stem of 30-D2 consisting only of A–U and G–U base pairs
is very unstable and might not exist at all (Figure 5A
and D). The secondary structure of 30-D3 is in good agree-
ment with the probing data, except for the lower stem of
this domain (Figure 5D). Thus, this stem might not exist,
or might adopt alternative conformations, as suggested by
cleavage by both RNase A and RNase V1 between
nucleotides 1643 and 1648 (Figure 5B–D).
Vif footprints were observed in the three structured
domains (Figure 5B–D). In 30-D1, Vif-induced protections
were split in several short regions but without a detailed
knowledge of its 3D structure, it is diﬃcult to estimate
how many Vif molecules bind to this ﬂexible domain. In
30-D2, the two protected regions located in a continuous
helical domain might be to far away to be produced by a
single Vif protein. Similarly, it is unclear whether the
protections observed in the 11nt stretch encompassing
the 30-end of 30-J23 and the 50-region of 30-D3 correspond
to a single or two contiguous Vif binding site(s). To note,
inhibition of the RNAse V1 cleavages in this region was
already observed at 0.3mM Vif, while protections in the
other domains required higher protein concentrations.
In vitro translation
As Vif was found to bind with high aﬃnity to hA3G
mRNA, including to the 50 and 30 UTRs which are often
involved in translational regulation (24,25), we studied the
eﬀects of WT Vif and Vif AALA on in vitro translation of
full length and truncated versions of hA3G mRNA
(Supplementary Figure S1 and Figure 6).
In order to ensure maximal activity of the WT and
mutant Vif proteins and to avoid the inhibitory eﬀect of
the Vif storage buﬀer on in vitro translation, these proteins
or human AspRS, which was used as a reference, were
synthesized by in vitro coupled transcription/translation
in rabbit reticulocyte lysate. These proteins were then
added to new transcription/translation reaction mixtures
including expression plasmids allowing translation of
hA3G from full-length hA3G, hA3G-50UTR, hA3G-
30UTR or hA3G-UTR mRNAs. As a control, we
also checked the eﬀects of WT Vif and AspRS on the
translation of luciferase. Radiolabeled proteins were then
analyzed by SDS–PAGE and quantiﬁed (Supplementary
Figure S1 and Figure 6).
When hA3G was translated from the full-length hA3G
mRNA for 15min, the amount of protein synthesized in
the presence of WT Vif was 45% of that obtained in the
presence of AspRS, indicating that Vif strongly repress
translation from this mRNA (Supplementary Figure
S1A and Figure 6A). Inhibition of translation from
hA3G mRNA by WT Vif further increased at longer incu-
bation times, and a  3-fold reduction of hA3G was
observed at 45min. Importantly, at 15min, WT Vif did
not signiﬁcantly reduce hA3G synthesis from hA3G-
UTR RNA, indicating that the UTRs of hA3G
mRNA play a crucial role in the translational repression
mediated by WT Vif (Supplementary Figure S1B and
Figure 6A). Further analysis showed that translation
from hA3G-30UTR RNA was repressed at the
same level as the full-length hA3G mRNA, whereas
642 Nucleic Acids Research, 2010,Vol. 38,No. 2hA3G-50UTR RNA behaved as hA3G-UTR RNA
(Supplementary Figure S1B–D and Figure 6A). These
results demonstrated that the 50UTR was necessary and
suﬃcient to allow Vif-mediated translational repression of
hA3G. As the incubation time increased to 45min, WT
Vif gradually repressed hA3G synthesis from all RNAs,
including hA3G-UTR and hA3G-50UTR RNAs.
However the amount of hA3G synthesized from these
RNAs was always twice that obtained from full-length
and hA3G-30UTR RNAs (Figure 6A). To further
ensure that the Vif-mediated translational repression of
hA3G was speciﬁc, we checked that WT-Vif had not
eﬀect on translation of luciferase (Supplementary Figure
S1E). In addition, adding MG132, a proteasome inhibitor,
in the rabbit reticulocyte lysate did not aﬀect the results
(Figure 6C), indicating that we were really looking at
diﬀerences in protein synthesis, and not at protein
degradation.
Finally, we tested whether the Vif multimerization
domain played a role in the inhibition of translation.
Indeed, the results we obtained with Vif AALA were
almost identical to (and do not show any statistically
signiﬁcant diﬀerence with) those obtained with WT Vif
(Figure 6B). They demonstrated that the Vif
multimerization domain is not required for Vif-mediated
repression of hA3G translation, and conﬁrmed the role of
the 50UTR of hA3G mRNA in this process.
DISCUSSION
In this work, we ﬁrst analyzed Vif binding to hA3G
mRNA using ﬁlter binding and ﬂuorescence assays
(Figures 2 and 3 and Tables 2 to 4). Even though both
techniques gave rather divergent dissociation constant
values (120 and 36nM, respectively, which will be dis-
cussed below) they allow to conclude that Vif binds
strongly to hA3G mRNA, especially as we used buﬀers
containing high concentrations of monovalent and
divalent cations to reduce unspeciﬁc electrostatic
interactions. We previously showed that Vif binds with
high aﬃnity and moderate cooperativity to the 50-region
of HIV-1 genomic RNA, while it binds very weakly or
does not bind at all to the central and 30-regions of this
RNA, to E. coli tRNAs and 5S RNA, and to the 30-region
of Drosophila melangaster bicoid mRNA, indicating that
Vif is not an unspeciﬁc RNA binding protein (20,21).
Indeed, the Kd (from ﬁlter binding assays) and Kobs
(from ﬂuorescence titration curves) values we determined
here for Vif binding to hA3G mRNA compare favorably
with the Kd (45–79nM) and Kobs (42–70nM) values for
Vif binding to 500nt long RNA fragments derived from
the HIV-1 genomic RNA (20,21).
There are however two noticeable diﬀerences between
Vif binding to HIV-1 genomic RNA and to hA3G
mRNA. First, with the latter RNA, we obtained rather
divergent Kd and Kobs values (compare Tables 2 and 3),
whereas Kd and Kobs values were very close with the
former RNA (20,21). Second, the binding density of Vif
to the hA3G mRNA fragments [one Vif molecule per
 100nt in the UTRs, and per  400nt in the hA3G
coding region (Table 3)] was much lower than the one
we observed with the HIV-1 RNA fragments [one Vif
molecule per  10nt for RNA fragments derived from
the 50-region of HIV-1 genomic RNA (20)]. This lower
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Figure 6. Eﬀect of Vif on the in vitro translation of hA3G. The amount
of hA3G synthesized from full-length hA3G, hA3G-UTR, hA3G-
50UTR and hA3G-30UTR RNAs in the presence of WT Vif (A)
or Vif AALA (B) was compared to that obtained in the presence of
human AspRS. Data are the mean values of four independent
experiments  SDs. (C) The amount of hA3G synthesized from full-
length hA3G and hA3G-UTR RNAs in the presence of WT Vif in
the absence or in the presence of MG132, a proteasome inhibitor, was
compared to that obtained in the presence of human AspRS.
Nucleic AcidsResearch, 2010, Vol.38,No. 2 643binding density to hA3G mRNA was conﬁrmed by our
RNase footprinting experiments, which showed much
more limited protections upon Vif binding to 50 and
30UTRs of hA3G mRNA (Figures 4 and 5), than to the
50-region of HIV-1 genomic RNA (21).
Interestingly, this low binding density might explain the
divergences between Kd and Kobs values observed with
hA3G mRNA fragments. As explained in the ‘Results’
section, our ﬁlter binding data imply that not all
complexes formed between Vif and hA3G mRNA
fragments were retained with the same eﬃciency on the
cellulose ﬁlters. Indeed, retention of the Vif/RNA
complexes probably increased with the Vif binding
density up to a threshold value above which retention
was complete. If the Vif binding density is high, as for
the HIV-1 genomic RNA fragments, most Vif–RNA
complexes are completely retained on the ﬁlters.
However, if the binding density is low, a bias is introduced
in the ﬁlter binding experiments that artiﬁcially increases
the Kd. If our assumption is correct the diﬀerences in the
Kd and Kobs values should be smaller for the
shorter RNAs, which have the higher Vif binding
density (Table 3), than for the longer ones. This hypoth-
esis is indeed veriﬁed, since the two techniques yielded
very similar Kd and Kobs values for the short hA3G-
50UTR and hA3G-30UTR RNAs, while divergent values
were obtained for the longer RNAs. To summarize,
(i) both techniques demonstrated that Vif has a stronger
aﬃnity for the 30UTR than for the 50UTR of hA3G
mRNA (Tables 2 and 3) and (ii) for longer RNAs, Kobs
derived from ﬂuorescence titrations are more reliable than
Kd values derived from ﬁlter binding assays. Interestingly,
the ﬂuorescence data showed that Vif has also a high
aﬃnity for the hA3G coding region (Table 3).
However, the Kobs values extracted from the ﬂuores-
cence titration curves using the McGhee and von Hippel
model (29) are also mean values of the individual Vif
binding sites. As shown in Figure 3, it was also possible
to analyze these data using the Scatchard equation in
order to extract the KSca value for the binding site
having the highest aﬃnity for Vif in hA3G-50UTR,
hA3G-30UTR and hA3G-UTR. This analysis revealed
that the highest aﬃnity Vif binding sites present in the
50 and 30UTRs of hA3G mRNA bind Vif with similar
aﬃnity (KSca=27 6 and 24 5nM, respectively), even
though the overall binding of Vif to the 50UTR is
signiﬁcantly weaker than to the 30UTR (Tables 2 and 3).
Thus, the secondary Vif binding sites located in the 50UTR
must have considerably weaker aﬃnity for this protein
than those located in the 30UTR of hA3G mRNA. In
contrast, the KSca of the highest aﬃnity Vif binding site
in hA3G-UTR (KSca=37 4nM), is identical, within
experimental errors to Kobs (46 7nM), indicating that
all binding sites present in the coding region of hA3G
mRNA have a similar aﬃnity for Vif.
We showed that mutation of the Vif multimerization
motif reduced the Vif oligomerization state but did
totally abolished it, suggesting that an additional region
is involved in Vif multimerization. Interestingly, this
mutation decreased the overall aﬃnity of the Vif AALA
protein for hA3G mRNA, but it did not decrease its
aﬃnity for the RNA sites with the highest aﬃnity for
Vif (Figure 3).
RNase footprinting revealed 3 to 4 Vif binding sites in
the 50UTR (Figure 4) and 3 to 6 Vif binding sites
in the 30UTR (Figure 5), in agreement with the ﬂuores-
cence data (Table 3). In addition, while most protections
in the 30UTR were obvious at 1.5mM Vif, only one Vif-
binding site, located in the lower stem of domain 50-D3,
was clearly detected at 1mM Vif. This observation is in
keeping with the overall higher aﬃnity of Vif for the
30UTR of hA3G mRNA, even though the protein
concentrations required to observe a footprint could
not be directly compared to those used in titration
experiments.
In the last part of this study, we analyzed the eﬀect of
Vif on the in vitro translation of hA3G from full-length
hA3G mRNA and mRNAs devoid of the 50UTR or/and
the 30UTR. Vif induced a 2-fold reduction of translation
that was strictly dependent on the 50UTR, while the
30UTR had no inﬂuence on translation (Figures 6 and
S1). Hence, there is no correlation between the relative
binding aﬃnity of Vif for the 50 and 30UTRs and their
role in Vif-mediated translational repression. The same
conclusion holds true when comparing WT Vif and Vif
AALA: mutation of the Vif multimerization domain
reduced the overall aﬃnity and speciﬁcity of Vif binding
to hA3G mRNA fragments (Table 2), but it didn’t
signiﬁcantly aﬀect translation (Figure 6). The fact that
wild-type Vif and Vif AALA have similar aﬃnities for
the highest aﬃnity Vif binding site located in the 50UTR
of hA3G RNA (Figure 3 and Table 4), may explain why
they have similar eﬀects on hA3G mRNA translation.
These results suggest that Vif does not simply physically
prevent scanning of the ribosomes through the 50UTR of
hA3G mRNA, but raise the possibility of a speciﬁc mech-
anism of Vif-mediated translational repression. Mutation
of the individual Vif binding sites we identiﬁed in the
50UTR of hA3G mRNA (Figure 4) should prove very
useful in order to decipher this mechanism. Numerous
examples in the literature showed that both the 50 and
the 30UTRs can be involved in translational regulation
(24,25). However, despite Vif binding to both UTRs of
hA3G mRNA, our data clearly show that the 30UTR is
dispensable for the translational regulation by Vif.
Otherwise, several lines of evidence indicated that
mRNAs ‘circularize’ during translation, and this phenom-
enon is also involved in some translational control
mechanisms (24,25). The experiments we performed in
the present study do not allow to rule out this possibility,
as our hA3G-30UTR expression construct, although
lacking the authentic 30-UTR of the hA3G mRNA,
contains the 30-UTR present in the expression vector.
The 50UTR-dependent translational repression of
hA3G by Vif was observed at all incubation times
(Figure 6). In addition, a general repression of hA3G
synthesis by Vif was gradually observed at increasing
incubation times, irrespective of the mRNA used for its
synthesis (Figure 6). This phenomenon ultimately resulted
in a 30–40% reduction in hA3G synthesis. Several groups
previously reported a negative impact of Vif on hA3G
translation. Pulse-chase experiments in cells transfected
644 Nucleic Acids Research, 2010,Vol. 38,No. 2with a tagged hA3G indicated a 30–78% decrease in
hA3G synthesis in the presence of Vif (7,10,38), while
Vif impaired hA3G translation by 70–75% in an
in vitro-coupled transcription/translation system (10).
Importantly, none of these studies used expression
vectors with the authentic 50UTR of hA3G mRNA (26).
Thus, these authors very likely only observed the time-
dependent, UTR-independent secondary eﬀect, while
they missed the main 50UTR-dependent, time-independent
eﬀect. Even though we cannot dismiss that possibility, we
think it is unlikely that the time-dependent inhibition of
translation is due to Vif aggregation, because (i) in all
these experiments (including ours) Vif was directly
synthesized in the in vitro translation system and (ii) one
would expect a decrease of Vif activity upon aggregation
(i.e. aggregation of Vif would likely decrease inhibition of
translation over time).
Since the seminal publication by Sheehy et al. (1), it has
become increasingly clear that the function of Vif is to
counteract the restriction factors hA3G and hA3F. Even
though several mechanisms have been proposed for Vif
function, the proteasome-mediated, Vif-induced degrada-
tion of these factors has been by far the most studied.
In agreement with previous studies suggesting that the
RNA binding properties of Vif are essential for its
function (23), our present work indicates that Vif
binding to hA3G mRNA, and particularly to its 50UTR
might be crucial for Vif function, by downregulating
hA3G translation. Even though other authors already
reported a negative eﬀect of Vif on hA3G translational
(7,8,10,38), our present work suggest that these authors
missed most of the eﬀect by working with expression
vectors lacking the authentic 50UTR of hA3G mRNA,
which had not been identiﬁed at that time. We are pres-
ently performing experiments to conﬁrm that Vif binding
to the 50UTR of hA3G mRNA inhibits hA3G synthesis in
cells, and to evaluate the contribution of this eﬀect to
HIV-1 replication in the presence of hA3G expression
(G. Mercenne et al., manuscript in preparation).
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